Tampa, FL – Dr. Eleanor E. Harris, clinical director and residency program director for Moffitt Cancer Center’s Radiation Oncology Program and service chief of the Breast and Gynecologic Clinical and Research divisions, has been accepted to the Hedwig Van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women.
ELAM is a unique leadership program developed in 1995 by Drexel University College of Medicine to increase the number of female faculty members in leadership positions in academic medicine, dentistry and public health. The fellowship program provides diverse women with the knowledge and skills needed to succeed in leadership roles in their field. Harris has been accepted to the program based on her significant experience and enthusiasm for leadership development.
“I am honored to participate in such a prestigious program that will allow me to develop the skill set and experience needed to excel at the next level,” Harris said. “I will have the opportunity to hone my leadership training and work closely with executive leadership at Moffitt and the University of South Florida.”
Harris will study among the future medical leaders of the nation. She will focus her studies on strategic finance, organizational dynamics, management and personal leadership effectiveness.
ELAM is for senior female faculty at the associate or full professor level who have demonstrated the greatest potential for assuming executive leadership positions at academic health centers within the next five years.
ELAM is a core program of the Institute for Women's Health and Leadership at Drexel University College of Medicine, Philadelphia, Pa. The Institute continues the legacy of advancing women in medicine that began in 1850 with the founding of the Female Medical College of Pennsylvania, the nation's first women's medical school and a predecessor of today's Drexel University College of Medicine.
About Moffitt Cancer Center
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 14 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.